Hope and Help of Central Florida's Thresa Giles to Speak at 2026 340B Coalition Summer Conference

Central Florida nonprofit CEO to share insights on 340B strategy, financial stewardship, and expanding access to care.
Winter Park, Fla. - July 10, 2026 - Thresa Giles, CEO of Hope and Help of Central Florida, Inc. [https://hopeandhelp.org/] (dba "Hope & Help"), will join the speaker lineup for the 2026 340B Coalition Summer Conference [https://www.340bsummerconference.org/], an annual gathering focused on the 340B Drug Pricing program in the United States, July 13th-15th. Each year, the conference seeks to unite leaders in healthcare and nonprofits with policymakers to explore emerging healthcare trends, regulatory developments, and strategies to strengthen the 340B program.

Giles currently serves as the executive leader at Hope & Help, a nonprofit healthcare organization dedicated to addressing HIV and other STIs through prevention, comprehensive treatment, education, peer resources and testing. Founded in 1988 by a group of friends seeking to support a friend with AIDS, Hope & Help provides community-centered care across seven counties in Central Florida through mobile testing units, bilingual services, harm-reduction programs and other resources.

Giles credits her extensive background in finance, contract administration, grant management, IT and investment strategy to her approach to leadership at Hope & Help. During her time as CEO, she has focused on expanding community partnerships, diversifying funding models and creating sustainable growth for the organization.

At this year's conference, Giles will share insights into evolving 340B program dynamics and the critical role of financial stewardship, compliance and strategic growth in expanding access to care for underserved communities, particularly to expanding access to HIV and STI prevention and treatment. In her presentation, she will draw from decades of leadership in finance, procurement, regulatory compliance and operational strategy.

"Participating in the 340B Coalition Summer Conference is an opportunity to engage in meaningful dialogue about the future of equitable healthcare access," said Giles. "I look forward to connecting with colleagues across the field and contributing to conversations that help strengthen and protect the 340B program."

The 340B Coalition Summer Conference will be held from July 13th-15th at the Gaylord National Hotel and Convention Center in National Harbor, Maryland. Giles will be speaking on July 14th from 1:30 p.m. to 2:45 p.m. during the "Track 3: 340B: Expanding Access to HIV and STI Prevention and Treatment" session, located in National Harbor rooms 12 and 13.

For more information about Hope and Help of Central Florida, Inc., please visit https://hopeandhelp.org/. Those interested in learning more about Thresa Giles' participation at the 2026 340B Coalition Summer Conference can contact Anna Kate Womack, Publicist at Otter PR, via email at annakate.womack@otterpr.com.

About Hope & Help:

Hope & Help [https://hopeandhelp.org/] is a Central Florida nonprofit healthcare organization dedicated to ending the HIV/STI epidemic through prevention, testing, treatment, and education. Founded in 1988, Hope & Help serves communities across the region through its bilingual clinic, mobile testing units, and harm-reduction programs, including IDEA Orlando, Florida's state-approved syringe-service initiative. Guided by a mission of equity, compassion, and access, the organization empowers individuals to take control of their sexual health and works toward a future where every person can live healthy, informed, and stigma-free.

Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hope-and-help-of-central-floridas-thresa-giles-to-speak-at-2026-340b-coalition-summer-conference]
City: ORLANDO
State: FL
Country: United States
Website: http://www.otterpr.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.